HomeADCT • NYSE
add
ADC Therapeutics SA
Previous close
$1.94
Day range
$1.86 - $2.00
Year range
$0.69 - $6.04
Market cap
192.41M USD
Avg Volume
414.72K
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 18.46M | 27.40% |
Operating expense | 52.19M | 3.80% |
Net income | -43.97M | 5.90% |
Net profit margin | -238.13 | 26.14% |
Earnings per share | — | — |
EBITDA | -35.23M | 1.69% |
Effective tax rate | -0.21% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 274.27M | -11.64% |
Total assets | 349.08M | -25.23% |
Total liabilities | 521.02M | -0.01% |
Total equity | -171.95M | — |
Shares outstanding | 96.69M | — |
Price to book | -1.09 | — |
Return on assets | -24.67% | — |
Return on capital | -30.07% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -43.97M | 5.90% |
Cash from operations | -25.04M | 31.71% |
Cash from investing | -216.00K | 67.32% |
Cash from financing | -879.00K | -351.86% |
Net change in cash | -25.85M | 30.34% |
Free cash flow | -27.25M | 10.01% |
About
Founded
2011
Website
Employees
274
